Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.
about
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsStatins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitisNon-alcoholic fatty liver disease: what the clinician needs to know.Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemicPleiotropic effects of statins in the diseases of the liverA Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLDCurrent Management of NAFLDNAFLD and Chronic Kidney DiseaseNonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment StrategyNon-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval PathwayManagement of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver diseaseBenefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetesCardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An updateRole of diet on non-alcoholic fatty liver disease: An updated narrative reviewNonalcoholic fatty liver disease: new treatmentsLipid-lowering agents in the management of nonalcoholic fatty liver diseaseOvercoming Challenges With Statin TherapyApplying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the futureUpdate on Inflammatory Biomarkers and Treatments in Ischemic StrokeImmune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic TargetsCardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature reviewManaging dyslipidemia in HIV/AIDS patients: challenges and solutionsThe Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver DiseaseNeck circumference, along with other anthropometric indices, has an independent and additional contribution in predicting fatty liver diseaseNon-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Promising therapies for treatment of nonalcoholic steatohepatitis.Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease.Vitamin E reduces liver stiffness in nonalcoholic fatty liver disease.Non-alcoholic fatty liver disease.Non-alcoholic fatty liver disease and cardiovascular risk.Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.Modern approach to the clinical management of non-alcoholic fatty liver diseaseStatin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges.Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysisSafety of statins: an updateManagement of nonalcoholic fatty liver disease: an evidence-based clinical practice review.Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients.Review article: prescribing medications in patients with cirrhosis - a practical guide.Nonalcoholic fatty liver disease and aging: epidemiology to management.New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.
P2860
Q22299426-FA7A2BD9-0235-4D6E-A74A-865E199A48BCQ24201595-89F3305B-B393-4516-A50B-478110428F68Q24563068-783A1126-ADBB-40C9-98CD-B32CA5F62240Q24563381-340AA022-6F9B-4AD7-AB9D-D07E71129460Q26741176-0E124599-DC9B-4574-AE60-EAF4990F3FABQ26752487-3AD778AE-EFAD-4A9D-982C-BD53CBF65B87Q26752729-BF906B7C-2BBE-4E28-B63C-3F1F766BC804Q26752759-2A2C8243-851B-4E83-AA96-36FB6F03A573Q26781753-0F2D72FE-2FBD-4853-B5CE-B27D3F96E275Q26800894-B9E00F93-DD25-44BE-AA74-F7A1ECF1AA49Q26827665-649F83A8-B44D-45F4-BA14-BC10705CDEB7Q26853571-ED8857CF-F2EE-4E8A-8220-9634AD978F64Q26997059-3A7897A1-DE52-4545-BC1F-EA3B3648A571Q27000333-9F3E206C-C0A2-44BC-90A8-91E5A0C1985CQ27021161-D8C1BA52-7304-4ACB-A416-FBD6565A5AEBQ27024352-EDBF27DE-E8AA-44A1-9A96-F038873026A0Q28073319-5E735748-F702-4199-9C5C-A7898549522CQ28074451-2280FD69-E3E6-4A4E-AB19-3739D159F34DQ28078744-20D94A0E-4D2A-48C4-846A-62D201BB486BQ28079713-22463D5D-7390-4DD1-9095-F270D510580EQ28081066-A9E70DB0-8F8E-435B-9A0B-A87C63539A59Q28084941-2FDF2B74-D4BD-4C09-B7D0-4957D39A28D4Q28086776-49BA37B8-A1C4-4CDC-9FBC-9995F82DD59DQ28543519-60B9A5E9-71A0-4BDD-A529-799EDA24E07CQ30235846-87ECBE4D-5955-41C1-9167-FEF8E5E0174EQ30248578-7E7B532D-BCE1-42BD-B04B-B604E196FEDFQ30375036-0C3E5AFC-C26A-4B77-B51E-303870C13AEEQ30396692-B5B80968-0B3D-4293-92DE-18831A183EBFQ30430392-049563E8-5D2E-49CB-ACDA-5485CBE786B9Q33706265-7FC16EF4-3061-436F-96FA-020382DFF5B8Q33724815-2F3BC519-E273-469B-8ACF-A1184B01E96AQ33886923-BBEA63AE-EA30-4CB1-841C-5953DDBB09D1Q33900403-C40B10C9-F32D-41AE-8396-EC7C8AC7A7CBQ33932951-859FE7EA-CF42-4592-BC3A-52EC8BAB046EQ33949312-17DB252B-3E10-4557-AD09-8CDBD25C8203Q34168532-6A5A0F50-D24C-400D-A3F5-EA7AF37D9069Q34169932-54340A00-84D6-4FCF-86CD-E0DFA598FA30Q34342554-0EF1484C-9A0C-4F33-B485-B58B6EE98B1AQ34366861-460C7B7B-282B-43B2-A4B7-383DC0B1D00CQ34398065-8F3344CC-F7D1-4202-8859-837BF79EB5C2
P2860
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Safety and efficacy of long-te ...... E) Study: a post-hoc analysis.
@en
Safety and efficacy of long-te ...... onary Heart Disease Evaluation
@nl
type
label
Safety and efficacy of long-te ...... E) Study: a post-hoc analysis.
@en
Safety and efficacy of long-te ...... onary Heart Disease Evaluation
@nl
prefLabel
Safety and efficacy of long-te ...... E) Study: a post-hoc analysis.
@en
Safety and efficacy of long-te ...... onary Heart Disease Evaluation
@nl
P2093
P1433
P1476
Safety and efficacy of long-te ...... E) Study: a post-hoc analysis.
@en
P2093
Asterios Karagiannis
Efstathios D Pagourelias
Eleni Theocharidou
GREACE Study Collaborative Group
Konstantinos Kargiotis
Konstantinos Tziomalos
Panagiotis Anagnostis
Theodora Griva
Thomas D Gossios
P304
P356
10.1016/S0140-6736(10)61272-X
P407
P577
2010-11-23T00:00:00Z